Taken together, these results propose that TP53 disruption, UM IGHV gene mutational status, mutated NOTCH1 and CD49d expression are the most powerful prognosticators in CLL. This evidence concerns the gene ITGA4 and B-cell chronic lymphocytic leukemia.